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Toxic epidermal necrolysis is a rare disease observed as a consequence of adverse reactions to drugs. It results in
the widespread apoptosis of epidermal cells and has a high mortality rate. The mechanisms leading to this
apoptosis are not yet elucidated. We investigated whether the cytokines present in the blister ﬂuid, which accu-
mulates under necrotic epidermis, originated from T lymphocytes and may play a role in the propagation of
keratinocyte apoptosis. Interferon gamma (IFN-c), soluble tumor necrosis factor alpha (TNF-a), soluble Fas ligand
(sFas-L) were present in much higher concentration in the blister ﬂuids of 13 toxic epidermal necrolysis (TEN)
patients than in control ﬂuids from burns. The results of RT-PCR studies, however, indicated that only IFN-c and to
a lesser extent interleukin (IL)-18 were produced by mononuclear cells present in the ﬂuid. That suggests that the
other cytokines also present (TNF-a, sFas-L, IL-10) rather originated from activated keratinocytes. Fas-L was indeed
overexpressed on the membranes of keratinocytes in lesional skin in situ. The Th1 proﬁle of T lymphocyte ac-
tivation found in the blister ﬂuid of patients with TEN is consistent with a key role for drug-specific cytotoxic T
lymphocytes (CTL) as previously reported, the activation of keratinocytes by IFN-c making them sensitive to cell-
mediated cytolysis. We propose the hypothesis that the production of Fas-L, TNF-a, and IL-10 by keratinocytes
could be a defense mechanism against CTL rather than a way of propagating apoptosis among epidermal cells.
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Toxic epidermal necrolysis (TEN) is an acute and severe
adverse reaction to drugs, characterized by the widespread
destruction of the epithelium of the skin and mucous mem-
branes (Lyell, 1979; Becker, 1998). This destruction by mas-
sive apoptosis (Paul et al, 1996) leads to a clinical pattern
resembling second-degree burns, with large sheets of ne-
crotic epidermis detached from the underlying dermis. The
death rate from TEN averages 30%. Even though very rare
TEN is a disease of interest because of a high impact on
the evaluation of the benefit/risk ratio of medicines and be-
cause the mechanisms of acute and extensive destruction
of the skin are still poorly understood.
At the onset of TEN, blisters often develop from the fluid
that accumulates in the gaps between the dead epidermis
and the dermis. High concentrations of mononuclear cells
are present in this blister fluid. In the first days of blister
formation, these cells are principally CD8 T lymphocytes
(Correia et al, 1993) often expressing natural killer (NK)
markers (Le Cleach et al, 2000) and that may exhibit a drug-
specific major histocompatibility complex (MHC) class I-re-
stricted cytotoxicity against autologous cells (Nassif et al,
2002). These findings strongly suggest that these cells are not
bystander lymphocytes but probably play a role in the de-
struction of epidermal cells. Anyhow, in skin biopsies of
early lesions of TEN, there are rather low numbers of CD8 T
lymphocytes within the epidermis (Miyauchi et al, 1991),
suggesting that the intervention of soluble mediators may
be necessary for amplifying the apoptosis of keratinocytes.
Several pathways could be implicated in the apoptosis of
keratinocytes in TEN. Tumor necrosis factor alpha (TNF-a)
(Paquet and Pierard, 1998), granzyme B, and perforin
(Yawalkar et al, 2000; Posadas et al, 2002) were found to
be overexpressed in lesional skin, but it has been suggested
that the Fas/Fas ligand (Fas-L) pathway was the key factor
(Viard et al, 1998).
To better understand how the relatively few lymphocytes
present within the skin lesions lead to the extensive
apoptosis of epidermal cells we: (1) measured the concen-
tration of a variety of soluble cytokines in the blister fluid of
13 patients with TEN in comparison with the blister fluids of
burns; (2) evaluated the synthesis and expression of some
cytokines by the mononuclear cells extracted from the blis-
ter fluids; and (3) looked at the effect of the blister fluid on
autologous keratinocytes.
Abbreviations: CTL, cytotoxic T lymphocytes; DMSO, dimethyl
sulfoxide; FACS, fluoresence activated cell sorter; FCS, fetal calf
serum; FITC, fluorescein isothiocyanate; ICAM, intracellular adhe-
sion molecule; IFN-g, interferon gamma; IL, interleukin; PE,
phycoerythrin; PBL, pheripheral blood lymphocytes; PMA, phorbol
myristate acetate; sFas-L, soluble Fas ligand; TEN, toxic epidermal
necrolysis; TGF-b, tumor growth factor b; TNF-a, tumor necrosis
factor alpha
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Results
Principal characteristics of the patients are summarized in
Table S1 (see online supplement).
Concentration of soluble cytokines in the blister ﬂu-
id Results of cytokine levels in the 13 blister fluids from TEN
patients are shown in Table S1. In all, 13 cases interleukin
(IL)-18 was present at a very high concentration. Interferon
gamma (IFN-g) was elevated in 12 cases, soluble tumor
necrosis factor alpha (sTNF)-a in nine, and soluble Fas lig-
and (sFas-L) in nine. High concentrations of IL-10 were
found in all 10 patients tested. On the other hand, IL-2 and
IL-12 were within normal serum values or not detectable in
all samples. IL-5 was slightly elevated in three of 13 cases,
while tumor growth factor b (TGF-b) was moderately ele-
vated in five of 13 and IL-15 in five of 13.
When we looked for possible correlation between cyto-
kine concentrations, we found significant positive correla-
tion (Spearman rank non-parametric test) between sTNF-a
and sFas-L (r¼0.59, p¼ 0.03) on one hand and between
IFN-g and sFas-L on the other (r¼ 0.66, p¼0.01).
We did not observe any significant difference when we
separated samples obtained early or late in the course of
the disease (p4 d vs44 d). The five cases without obvious
drug cause did not differ from the eight cases with a prob-
able drug origin. The serum of some of the 13 patients had
been obtained at the same time than blister fluid. When
tested for IL-10 (patient #12) and IL-18 (patients #5, #6, #7,
#9, #10, #11, and #12), all contained normal concentrations
(not detectable for IL-10 and always o100 pg per mL—
mean 46  17—for IL-18). In addition, the serum concen-
tration of IL-10 was also not measurable in six TEN patients
not included in the present study.
In the control blister fluids from burned patients (Table I),
we found high concentrations of IL-18, slight elevations of IL
10 in 2 cases, of sTNF-a in one, and normal levels of IFN-g
and sFas-L.
Expression and synthesis of cytokines by mononuclear
cells contained in the blister ﬂuid As shown in Fig 1,
lymphocytes from the blister fluid of TEN patients were
strongly marked by granzyme B antibody (mean 85% pos-
itive cells) in the five patients tested, but not by anti-Fas-L
antibody (mean 3% positive cells) in the three patients
tested, two of them (eight and 12) having high concentration
of sFas-L in the supernatant of the same blister fluid.
Table II shows the content of messenger RNA for a variety
of cytokines in the mononuclear cells from the blister fluid of
three TEN patients as compared with (1) the unstimulated
blood mononuclear cells from five normal controls and (2)
phorbol myristate acetate (PMA)-stimulated blood mononu-
clear cells from one normal control. Blister fluid cells differed
from non-activated control cells only by higher contents in
mRNA for IFN-g and a lower content of mRNA for Fas-L. On
the other hand, they were similar to non-stimulated control
cells for the synthesis of IL-2, IL-10 and TNF-a. They differed
from stimulated normal peripheral blood lymphocytes (PBL)
by a lower production of all cytokines.
The production of IL-18 was evaluated in a separate
experiment (see material and methods). Blister fluid cells
differed from positive control cells (monocyte-derived den-
dritic cells) by a much lower content in IL-18 mRNA (100-
Table I. Cytokine concentrations in the blister ﬂuids of three













1 1 9 18 1531 7
2 0 0 18 650 19
3 5 0 18 528 31
aN, upper limit of normal serum value. All results are expressed in pg
per mL.
TEN, toxic epidermal necrolysis; TNF-a, tumor necrosis factor alpha;
IFN-g, interferon gamma; sFas-L, soluble Fas ligand; IL, interleukin.
Figure1
Granzyme B and Fas L expression by blister fluid lymphocytes.
Blister fluid lymphocytes were stained with PE-labeled anti-granzyme B
and with biotinylated anti-Fas L and analyzed by flow cytometry.
Table II. Reverse transcription real-time PCR mRNA analysis of various cytokine gene expression
in blister ﬂuid cells and in resting or activated control cells
Fas-L IL-2 IFN-c TNF-a IL-10 IL-18a
Blister fluid cells (patient #8) 0 12.5 991 1381 8 0.09
Blister fluid cells (patient #11) 93.3 4.3 3779 1287 125 0.09
Blister fluid cells (patient #12) 0.3 1 2024 0 1.5 0.04
Control PBMC (n¼ 5) 169  46 6.6  5.3 241  360 8713  12,798 47.8  57.6 0.03  0.01
PMA-stimulated PBMC 4233 11,607 31,178 17,994 667 ND
Results are expressed as mean of the ratio target gene AU per b2 microglobulin AU  106.
aFor IL-18, results are expressed in DDCt (see ‘‘Patients and Methods’’).
Fas-L, Fas ligand; IL, interleukin; IFN-g, interferon gamma; IL, interleukin; PBMC, peripheral blood mononuclear cells; PMA, phorbol myristate acetate;
TNF-a, tumor necrosis factor alpha, ND, not determined.
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fold less). Yet, IL-18 mRNA expression was 3-fold higher in
blister fluid cells than in resting control PBL.
In situ expression of Fas and Fas-L by keratinocytes As
shown with two representative cases in Fig 2, keratinocytes
of lesional skin with non-detached or partially detached ep-
idermis expressed Fas-L on their membranes. On the other
hand, Fas expression was mostly restricted on the basal cell
layer, when it was strongly expressed on invading mononu-
clear cells both in the upper dermis and in the epidermis.
Blister ﬂuid induced activation but not apoptosis of au-
tologous keratinocytes Keratinocytes cultured from hair
follicles, obtained after recovery in patient 12, were incubated
for 48 h with cell-free supernatant of autologous blister fluid.
As shown in Table S1, this fluid contained especially high
amounts of IFN-g, TNF-a, and sFas-L. Incubation resulted in
activation of cultured keratinocytes as evidenced by expres-
sion of HLA-DR and CD54 (Fig 3), but we did not find any
sign of apoptosis with annexin V labeling (data not shown).
Discussion
In 13 patients with TEN, we studied the cytokines present
within the blister fluids. Our findings provided additional in-
formation on the mechanisms involved in the widespread
destruction of the epidermis that characterize this disease.
Three cytokines were found at high concentrations in all
tested samples: IL-18, IFN-g, and IL-10. Variable amounts
of TNF-a and sFas-L were found in about two-thirds of
cases. Other evaluated cytokines were present at low con-
centrations in a minority of cases (IL-5, IL-15, TGF-b) or
were not detectable in any sample (IL-2, IL-12).
To our knowledge, the presence of high amounts of IL-18
in the blister fluids of diseased skin has never been reported
before. We had tested IL-18 in TEN because it is the prin-
cipal IFN-g-inducing factor produced by human keratin-
ocytes (Stoll et al, 1997). Interestingly, IL-18 induces not
only IFN-g, but the Th1 cytokines TNF-a and IL-15, as well
as Fas-L. It also stimulates cytotoxic T cells. We were an-
yhow surprised to find elevated concentrations of IL-18 also
in the blisters from burned patients, since the mechanisms
of the two diseases are quite different. Apoptosis has been
established as the mechanism of cell death in TEN (Paul
et al, 1996), whereas necrosis is predominant in burns
(Matylevitch et al, 1998). These finding may suggest that IL-
18 has been preformed in keratinocytes and released by
dying cells, whatever the mechanism of death has been. As
we found, however, that mononuclear cells present in the
blister fluid also produced some amounts of IL-18, it seems
likely that mononuclear cells also contribute to the high
amounts found in the blister fluid. Nevertheless, IL-18 may
enhance the production of IFN-g in TEN cases, but not in
burns because of a much lower concentration of T cells in
burn fluids. Actually, in burn fluid the concentration of cells
is 10 times lower than in TEN fluid and T lymphocytes ac-
count for less than 10% of these cells in contrast with more
than 50% in TEN (Correia et al, 1993).
The presence of IL-10 in both types of fluids, although
the concentration was higher in TEN as previously reported
(Correia et al, 2002), also suggests that it is produced by
keratinocytes. That IL-10 originated from keratinocytes in
TEN patients was indirectly supported by the RT-PCR study
of blister fluid cells. Actually, the mononuclear cells present
in the blisters contained no more IL-10 mRNA than unstim-
ulated PBL from normal controls. IL-10 is chemotactic for
peripheral blood CD8þ T cells and may contribute to the
recruitment of CD8þ T lymphocytes to the blister fluid of
patients with TEN. In addition, IL-10 inhibits the production
of inflammatory cytokines such as TNF-a or IL-6 and is a
potent suppressor of the effector functions of macrophag-
es, T cells, and NK cells. It may act as a downregulator
of these cell functions and as a physiological defense
Figure 2
Immunohistochemical analysis of ker-
atinocyte expression of Fas and Fas-L.
Cryosections of biopsies of lesional skin
from two patients were incubated with a
rabbit polyclonal anti-human Fas-L and a
mouse monoclonal IgG1 anti-Fas as de-
scribed in Patients and Methods. One
patient had a diffuse labeling of keratin-
ocytes with anti-Fas-L (a) and labeling of
basal keratinocytes with anti-Fas (b), the
other patient had a faint labeling of kera-
tinocytes with anti-Fas-L (c) and no labe-
ling with anti-Fas (d).
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mechanism against excessive tissue inflammation (Enk and
Katz, 1992; Spits and Malefyt, 1992).
The absence of IL-2, confirmed by a functional test and by
RT-PCR, may be considered surprising in a fluid where many
activated T cells expressing CD25 are found (Le Cleach et al,
2000). But these cells are mostly CD8 cytotoxic Tcells, which
have been already shown to produce little or no IL2 (Chouaib
et al, 1988; Fong and Mosmann, 1990).
The main characteristic of TEN fluid, compared to burn
fluid, was the nearly constant presence in high concentra-
tions of IFN-g, sTNF-a, and sFas-L, with some correlation
between the concentrations of these three cytokines. IFN-g
was the cytokine with the highest concentration, and always
present in TEN when not found in burns. IFN-g is not known
to be produced by keratinocytes. Not surprisingly high levels
of IFN-g mRNA were detected in blister fluid mononuclear
cells confirming that these cells were the source of IFN-g.
The high level of production of IFN-g, contrasting with the
inconstant presence and low concentrations of IL-5, points to
a Th1 pattern of activation of T lymphocytes in TEN.
Significantly higher amounts of TNF-a have been previ-
ously found in TEN blisters than in burns (Correia et al,
2002). Both TNF-a and Fas-L can be produced by keratin-
ocytes and their production is increased by IFN-g (Arnold
et al, 1999). By RT-PCR we found that blister fluid cells did
not express more TNF-a and Fas-L transcripts than control
lymphocytes. Furthermore, we did not find a significant ex-
pression of the Fas-L protein on these cells by fluoresence
activated cell sorter (FACS) analysis. On the other hand,
immunolabeling of keratinocytes in biopsy samples of les-
ional skin demonstrated an overexpression of membrane
Fas-L. Taken together, these results suggest that sFas-L
present in the blister fluid of TEN had been produced by
activated keratinocytes. Conflicting results had been previ-
ously obtained on this point. One study showed that in vitro
cytokine-activated keratinocytes expressing membrane
Fas-L did not release measurable amounts of sFas-L
(Arnold et al, 1999), when another one found sFas-L in the
supernatant of cultured keratinocytes (Berthou et al, 1997).
When incubated for 48 h with cell-free supernatant of
autologous blister fluid, cultured keratinocytes were acti-
vated but did not undergo apoptosis. This result suggests
that there is enough IFN-g to activate keratinocytes but not
enough sFas-L to induce Fas-mediated apoptosis. This is
not really a surprise considering that the concentration of
sFas-L in the blister fluid was about 5 ng per mL, when
human recombinant sFas-L induced apoptosis of keratin-
ocytes at much higher concentrations (IC50¼89–232 ng per
mL) (Viard-Leveugle et al, 2003).
These results do not exclude that the over expression of
membrane Fas-L could participate in the suicidal apoptosis
of keratinocytes. This had been proposed (Viard et al, 1998)
on the basis of experiments showing that keratinocytes
from TEN lesions induced apoptosis on Jurkat cells. Where-
as Jurkat cells express high levels of Fas we, after others
(Paquet et al, 2002), found no gross overexpression of Fas/
CD95 by keratinocytes of lesional skin of TEN. Since an
overexpression of Fas by keratinocytes has been observed
in many clinical situations where the apoptosis is much
more limited than in TEN, e.g., UV irradiation (Bang et al,
2002), contact dermatitis or pemphigoid (Sayama et al,
1994), we consider that the hypothesis that dissemination of
apoptosis in TEN is Fas mediated lacks definite support.
On the other hand, we have previously demonstrated
that cells present in the blister fluid behave as drug-specific
CTL (Nassif et al, 2002). The activation of keratinocytes by
Figure 3
Activation of keratinocytes from one TEN patient by autologous
blister fluid. Keratinocytes obtained from hair follicles of patient 12, after
recovery, were cultured for 48 h with 1/2 or 1/10 dilutions in culture me-
dium of autologous blister fluid. (A) After a 48 h incubation in culture
medium alone, keratinocytes did not express HLA-DR and CD54/ICAM-1.
(B) After 48 h incubation with autologous blister fluid, diluted 1/10 (normal
line) or 1/2 (bold line), keratinocytes expressed HLA-DR and CD54/ICAM-
1 (78  10% and 85  5%, respectively with 1/2 dilution). (C) After 48 h
incubation with 1/2 dilution of blister fluid from a burned patient, HLA-DR
and CD54/ICAM-1 were not expressed. (D) When incubated for 48 h with
IFN-g (500 U per mL) keratinocytes expressed as expected HLA-DR and
CD54/ICAM-1 (90%  5% and 93%  5%, respectively).
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IFN-g is an important step in making them sensitive to lysis
by CTL (Schnyder et al, 1998).
Taken together, these results support the following hy-
potheses on the mechanism of TEN: the key effectors are
drug-specific CD8 CTLs (Nassif et al, 2002) engaged in a
Tc1 pathway. The secretion of IFN-g by these cells results in
activation of keratinocytes, including the overexpression of
MHC class I molecules, and makes them sensitive to MHC
restricted, perforin, and granzyme B mediated apoptosis.
The release of TNF-a and sFas-L by keratinocytes is a
marker of activation and a part of innate defense mecha-
nisms of epidermal cells. These cytokines might contribute
to the dissemination of keratinocyte death. But we can also
postulate that together with the production of IL-10, the
release of TNF-a and the overexpression of Fas-L are part
of a defense mechanism of epidermal cells against invading
CTLs (Berthou et al, 1997).
Patients and Methods
Patients The blister fluids were collected from 13 patients with
clinical and pathologic criteria of TEN. The study had been ap-
proved by an ethical committee (CCPPRB, Pitie`-Salpeˆtrie`re, Paris,
France) and all patients (or relative in case of incapacity) provided
informed consent to sampling of blood and blisters.
As controls, we studied the blister fluids obtained from three
patients suffering from localized second-degree thermal burns.
Supernatants and cells from blister ﬂuid Samples of blister fluid
were obtained by puncture of several blisters within 2 days after
hospitalization, i.e., 1–14 d after the onset of the skin reaction. It
was not possible to collect adequate information on the duration of
individual blisters before sampling. Fluid obtained by direct aspi-
ration was centrifuged (1000  g) and supernatants were collected
and stored at o201C until use. Cells from the pellet were resus-
pended in 20% fetal calf serum (FCS) and 10% dimethyl sulfoxide
(DMSO) containing medium (RPMI 1640 supplemented with pen-
icillin 100 U per mL, streptomycin 100 mg per mL, glutamine 2 mM,
sodium pyruvate, non-essential amino acids, HEPES buffer—Flow
Laboratories Glasgow, UK), frozen and stored in liquid nitrogen. We
know from prior studies that these cells are about 80% lymph-
ocytes and 20% monocytes. (Le Cleach et al, 2000). From the
distribution of cell size in FACS analyses in three patients included
in the present study, the proportion of lymphocytes among living
cells was estimated to 75%, above 95%, and 90%, respectively.
Cytokines measurement in supernatant of blister ﬂuid We quanti-
fied the following cytokines by a sandwich ELISA according to
standard protocols. Commercial ELISA kits from Immunotech
(Marseille, France) were used for quantifying sTNF-a, IL-5, IFN-g
and sFas-L. Quantikine assays (R&D systems, Minneapolis, Min-
nesota) were used for TGF-b1, IL-12, IL-15, IL-18, and Diaclone
used for measuring IL-2 and IL-10. All kits were used as specified
by the manufacturers.
IL-2 measurement was also performed by a biological assay.
Cells from the CTL-L2 cell line were washed in RPMI 1640 and
suspended in RPMI 1640 completed with 10% bovine calf serum
at 5  104 cells/well in a volume of 200 mL in a U-bottom micro-
plate. Supernatants were added and incubated for 3 d at 371C in
5% CO2. After 3 d incubation, microcultures were pulsed with 1 mCi
per well of methyl-[3H]thymidine (20 mL) and cells harvested 7 h
later and counted in a microplate b-counter. The IL-2 sample levels
were determined by comparison to a standard curve using different
concentration of IL-2.
Cytokine concentrations were expressed in pg per mL. Normal
values were chosen as the upper limit of concentration in normal
human serum according to figures provided by the manufacturers.
Culture of human keratinocytes About 20 hair follicles were
plucked from the scalp and the bulk of the hair shafts cut off as
described earlier (Limat and Noser, 1986). The follicles were im-
mersed in the Dulbecco-modified Eagle’s medium (DMEM) buff-
ered with 25 mM HEPES and supplemented with 400 U per mL
penicillin 400 mM per mL streptomycin. A single cell suspension
was obtained by incubating the follicles for 30 min. at 371C with
200 ml 0.1% trypsin (1:250) and 0.02% EDTA each in phosphate-
buffered saline (PBS). The dissociated keratinocytes were centri-
fuged for 10 min. at 200  g. The culture medium consisted of
three parts of DMEM containing sodium pyruvate and 1 g per liter
glucose, and 1 part of Ham’s F-12 medium, supplemented with
10% FCS, 5 mg per mL insulin (Sigma, St. Quentin Fallavier,
France), 0.10 nM cholera toxin (Sigma), 0.4 mg per mL hydrocor-
tisone (Upjohn, St. Quentin en Yvelines, France), 2 nM 3,30,5-
triiodo-L-thyronine (Sigma), 0.135 mM adenine (Sigma), 10 ng per
mL epidermal growth factor (Sigma), penicillin 50 U per mL, strep-
tomycin 50 mg per mL, and amphotericine-B 2.5 mg per mL (In-
vitrogen, Cergy Pontois, France). The keratinocytes were seeded
at a density of 2–3  103 cell per cm2 on a 3T3 feeder layer
(2  103 cell per cm2). The 3T3 cell proliferation had been halted by
a treatment with g irradiation at 60 Gy. The culture was incubated
at 371C and 5% CO2-humidified atmosphere. After 2 wk in primary
culture, keratinocytes were detached by trypsin.
Immunostaining of blister ﬂuid cells and keratinocytes Phenotypic
analysis was performed on thawed cells, using a flow cytometer XL
coulter after staining with fluorescent monoclonal antibodies
against granzyme B (Caltag, San Francisco, California), Fas, Fas-
L, CD54/intracellular adhesion molecule (ICAM)-1 (UB2-FITC (flu-
orescein isothiocynate), 4H9-biotin and H11-FITC, S45-FITC, re-
spectively, Beckman Coulter, Mareseille, France) and HLA-DR
(Pharmingen, San Diego, California).
Immunohistochemical analysis of keratinocyte expression of Fas
and Fas-L After rehydratation and inhibition of endogenous per-
oxidases, 6 mm thin cryosections of biopsies of lesional skin were
incubated with primary specific or isotype control irrelevant anti-
bodies for 30 min, then incubated with a multi-species biotinylated
second antibody for 10 min before the addition of streptavidin–
peroxidase reagent for 10 min. (Ultratech HRP Streptavidin–Biotin,
Immunotech, Universal Detection System, Marseille, France).
The amino-ethyl-carbazol (AEC) substrate-chromogen (Beck-
man-Immunotech, Marseille, France) was used to reveal antibody
fixation. Sections were counterstained with Mayers hematoxylin
before glycerol mounting.
A rabbit polyclonal anti-human Fas-L (N20, Santa Cruz, Tebu,
France) diluted to 1/50, and a mouse monoclonal IgG1 anti-Fas
(UB2, Beckman Coulter, Immunotech) diluted to 1/20 were used to
detect Fas/Fas-L expression, respectively.
Isotype control antibodies were included in each experiment.
To assess the cell infiltrating area on the sections, a Larborlux S
Leitz (Leica Microsystems, Rueil-Malmaison, France) microscope
was used with a  25 objective.
Study of keratinocyte activation and apoptosis with ﬂow cytome-
try Subconfluent keratinocyte cultures derived from hair follicles of
patient #12 were incubated for 48 h. with several dilutions in the
culture medium (1/20 to 1/2) of autologous blister fluid (containing
the highest concentration of sFas-ligand) or with IFN-g 500 U per
mL. After detaching the keratinocytes, membrane immunostaining
was performed with specific antibodies against HLA-DR, CD54/
ICAM-1, and annexin V-FITC.
RNA isolation and quantiﬁcation of gene expression by real-time
quantitative RT-PCR In the blister fluid cells of three selected pa-
tients, we investigated mRNA expression level of IL-2, IL-10, IL-18,
IFN-g, TNF-a, and Fas-L/CD95L. Total mRNA was purified using
Rneasy kit (Qiagen SA, Courtaboeuf, France). The sequence of
primers and probes and PCR parameters are indicated in Table S2.
All nucleotide primers were targeted to separate exons of the
genes of interest. The expression levels of tested cytokines were
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analyzed in first-strand cDNA reaction (RT) samples, each con-
taining: 1–10 mg total RNA isolated from blister fluid cells or control
PBL, 16 U per mL M-MLV reverse transcriptase (Gibco-BRL, Life Tech-
nologies, Cergy-Pontoise, France), 4 mM Oligo-(dT) 12-18 (Amer-
sham-Pharmacia Biotech, Saclay, France) and 0.8 mM mixed dNTP
(Amersham-Pharmacia Biotech, Saclay, France). For IL-2, IL-10, IFN-
g, TNF-a, Fas-L/CD95L quantitative PCR was performed using the
LightCycler System (Roche Diagnostics, Meylan, France) with hybrid-
ization probes that use the fluorescence resonance energy transfer
(FRET) phenomenon (Wittwer et al, 1997). A standard curve was
made by PCR of eight dilutions (108–10 copies) of the corresponding
‘‘quantitative DNA standard’’ (QDS), generated by using the ‘‘looped
oligo’’ method (Sarkar and Bollander, 1994). The PCR products were
cloned in plasmids for storage stability of the QDS. The relative value
for amplification of each sample was evaluated using the Light Cycler
analysis software using the Ct value (‘‘Second Derivative Maximum’’,
version 3.5; Roche). Amplification of the b2 microglobulin (b2mg)
gene served to monitor the quality of the RNA isolation and the
efficiency of the reverse transcription reaction. The b2mg gene was
chosen as housekeeping control because its expression remained
relatively constant. The magnitude of target gene expression was
calculated as copies number of target gene cDNA per 106 copies
of b2mg cDNA. We obtained the same relative results when the
number of copies of the target gene cDNA was calculated per 103
copies of GAPDH cDNA (data not shown). IL18 mRNA expression
was evaluated by relative quantification of real-time-PCR accord-
ing to Gibson et al (1996) cDNA dilution series of calibrator cell
were run to set up a standard curve for IL-18 and GAPDH (as
HKG), and the Ct values were plotted against the log cDNA con-
centration added. Monocyte-derived dendritic cells were used as
calibrator cells and compared either to blister fluid cells or control
peripheral blood mononuclear cells of healthy donors. By using the
obtained linear graphs, the differences in Ct values were deter-
mined for each sample and were expressed as relative percentage
of mRNA present in the reference dilution of the calibrator cells,
according to the DDCt method, after adjustment of PCR efficiency
with the RelQuant software (Roche). Each PCR experiment was
carried out in duplicates and at least two times.
Statistical analyses Analyses were performed with Student’ t test
and Spearman non-parametric correlation using InStat.2 software
(GraphPad Software, San Diego, California).
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